Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Apr 2023 for Cipher Pharmaceuticals Inc., €61k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Diane Gajewczyk: trading record in brief
Diane Gajewczyk discloses dealings in Cipher Pharmaceuticals Inc. to SEDI. We count 6 filings; the first trade dates from 4 June 2018 and the latest from 29 March 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 9 April 2023, reports an option exercise of €61k in Cipher Pharmaceuticals Inc. Typically, a trade is published a median of 11 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Diane Gajewczyk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
24,602 shares@ CA$3.6762.6% of flowCommon SharesTSXSEDI:4113649
6,065 shares@ CA$3.7515.8% of flowCommon SharesTSXSEDI:4113647
1,552 shares@ CA$3.724.0% of flowCommon SharesTSXSEDI:4113648
24,603 shares@ CA$1.05100.0% of flowCommon SharesTSXSEDI:3750769
1,059 sharesCommon SharesTSXSEDI:3555811
Common SharesTSXSEDI:3555810
6 of 6 declarations
